SCHEMBL29960874

SCHEMBL29960874

C=CCCOc1cccnc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 1/20 0.51
KDM4E B2RXH2 3/20 0.46
LMNA P02545 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
TRIM24 O15164 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
MAPT P10636 4/20 0.37
MAPK1 P28482 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GAA P10253 1/20 0.36
EDNRA P25101 2/20 0.36
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4072898 1.00 S1PR4 (0.51) S1PR4KDM4ELMNASMN1; SMN2RAB9A
SCHEMBL15467609 0.92 S1PR4 (0.50) S1PR4KDM4ELMNASMN1; SMN2RAB9A
SCHEMBL1631630 0.82 S1PR4 (0.46) S1PR4KDM4ELMNATRIM24TRIM33
SCHEMBL29960349 0.77 KDM4E (0.41) KDM4ELMNASMN1; SMN2RAB9ANPC1
SCHEMBL16581566 0.77 KDM4E (0.62) KDM4ELMNASMN1; SMN2MAPTMAPK1
SCHEMBL9051415 0.77 MAPT (0.60) KDM4ELMNASMN1; SMN2RAB9ANPC1
SCHEMBL15432573 0.77 KDM4E (0.48) KDM4ELMNASMN1; SMN2RAB9ANPC1
SCHEMBL9980697 0.77 S1PR4 (0.55) S1PR4KDM4ELMNASMN1; SMN2RAB9A
SCHEMBL91148 0.77 S1PR4 (0.55) S1PR4KDM4ELMNASMN1; SMN2RAB9A
SCHEMBL4155091 0.77 S1PR4 (0.55) S1PR4KDM4ELMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed